The way nephrology develops in the new millennium is bound to be affected b
y changes in the nephrologist's clinical environment, as well as by the pro
gress made in basic research which will need to find a clinical application
. The nephrologist can expect to be more and more involved in renal substit
ution therapy, not just providing the treatment, but also managing the cost
of the service. In the field of nephropathology, the highest expectations
surround molecular biology and its application to both acquired and heredit
ary renal disease; the goal is to find an outlet for gene therapy in clinic
al practice. Artificial substitution therapy will focus chiefly on the proj
ect of 'intelligent dialysis', whereby biological and diagnostic components
are combined according the specific needs of the individual patient. The i
deal scenario for renal transplantation in the coming millennium would be o
ne where donor supply matches the demand (xenotransplant?), where immunomod
ulation is perfected, and where diagnoses are based on precise biomolecular
events observed in real time. Copyright (C) 2000 S. Karger AG, Basel.